JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5201
PUT
Upbound Group
UPBD
$928M
| $21K | ﹤0.01% |
+1,000
| New | +$18.4K |
2019 Q1
0 quarters
|
|
|
ZNH
5202
DELISTED
China Southern Airlines Company Limited
ZNH
| $21K | ﹤0.01% |
+488
| New | +$18K |
2019 Q1
0 quarters
|
|
|
AVEO
5203
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $21K | ﹤0.01% |
2,615
-123
| -4% | -$1.27K |
2017 Q4
5 quarters
|
|
5204
Cogent Biosciences
COGT
$5.38B
| $20K | ﹤0.01% |
1,161
-8,416
| -88% | -$144K |
2018 Q2
3 quarters
|
|
5205
WisdomTree Japan SmallCap Dividend Fund
DFJ
$453M
| $20K | ﹤0.01% |
300
-2,000
| -87% | -$135K |
2018 Q1
4 quarters
|
|
5206
Liquidia Corp
LQDA
$2.56B
| $20K | ﹤0.01% |
1,729
+482
| +39% | +$7.72K |
2018 Q3
2 quarters
|
|
5207
Nuveen Minnesota Quality Municipal Income Fund
NMS
$64M
| $20K | ﹤0.01% |
1,500
| – | – |
2015 Q3
14 quarters
|
|
5208
Schwab US Large- Cap ETF
SCHX
$74.5B
| $20K | ﹤0.01% |
1,800
-271,728
| -99% | -$2.94M |
2018 Q3
2 quarters
|
|
|
SWZ
5209
Swiss Helvetia Fund
SWZ
$74.8M
| $20K | ﹤0.01% |
2,581
| – | – |
2015 Q4
13 quarters
|
|
|
JPT
5210
DELISTED
Nuveen Preferred and Income Fund
JPT
| $20K | ﹤0.01% |
894
| – | – |
2018 Q4
1 quarter
|
|
|
LOGC
5211
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $20K | ﹤0.01% |
1,982
-463
| -19% | -$4.31K |
2018 Q4
1 quarter
|
|
|
MBII
5212
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $20K | ﹤0.01% |
13,309
-625
| -4% | -$954 |
2018 Q2
3 quarters
|
|
|
ISRL
5213
DELISTED
Isramco Inc
ISRL
| $20K | ﹤0.01% |
181
-51
| -22% | -$5.8K |
2017 Q4
5 quarters
|
|
5214
Aquestive Therapeutics
AQST
$571M
| $19K | ﹤0.01% |
2,747
+1,412
| +106% | +$9.89K |
2018 Q3
2 quarters
|
|
5215
Kenon Holdings
KEN
$3.15B
| $19K | ﹤0.01% |
981
+787
| +406% | +$14.6K |
2017 Q1
8 quarters
|
|
5216
Kopin
KOPN
$913M
| $19K | ﹤0.01% |
14,416
-262,694
| -95% | -$352K |
2017 Q4
5 quarters
|
|
5217
Kornit Digital
KRNT
$751M
| $19K | ﹤0.01% |
795
-6,518
| -89% | -$139K |
2017 Q1
8 quarters
|
|
5218
Global X Lithium & Battery Tech ETF
LIT
$1.45B
| $19K | ﹤0.01% |
+676
| New | +$19.3K |
2019 Q1
0 quarters
|
|
5219
Maui Land & Pineapple Co
MLP
$312M
| $19K | ﹤0.01% |
1,655
-643
| -28% | -$7.23K |
2017 Q4
5 quarters
|
|
5220
ProShares Short QQQ
PSQ
$580M
| $19K | ﹤0.01% |
+130
| New | +$20.3K |
2019 Q1
0 quarters
|
|
5221
Syndax Pharmaceuticals
SNDX
$1.57B
| $19K | ﹤0.01% |
3,620
+40
| +1% | +$228 |
2016 Q4
9 quarters
|
|
5222
US Commodity Index
USCI
$409M
| $19K | ﹤0.01% |
500
| – | – |
2018 Q2
3 quarters
|
|
5223
ProShares VIX Mid-Term Futures ETF
VIXM
$49.9M
| $19K | ﹤0.01% |
900
+877
| +3,813% | +$20.2K |
2018 Q4
1 quarter
|
|
|
XOMA
5224
DELISTED
Xoma
XOMA
| $19K | ﹤0.01% |
1,553
-2,221
| -59% | -$30.4K |
2017 Q3
6 quarters
|
|
|
CWBR
5225
DELISTED
CohBar, Inc. Common Stock
CWBR
| $19K | ﹤0.01% |
193
-9
| -4% | -$908 |
2018 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.